These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 1512943)

  • 1. [Penetration of levofloxacin in bile].
    Mizuno A; Suzuki T; Taniguchi M; Yura J; Shinagawa N; Ishikawa S; Mashita K; Suzui K; Ishikawa M; Ishihara H
    Jpn J Antibiot; 1992 May; 45(5):569-75. PubMed ID: 1512943
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Chemotherapy of biliary tract infections (XXXVII). Excretion into bile and gallbladder tissue levels of levofloxacin and its clinical effect in biliary tract infections].
    Tanimura H; Ohnishi H; Okamura T; Uenishi M; Ichimiya G; Kobayashi Y; Aoki Y; Oka S; Yamamoto S; Shimada K
    Jpn J Antibiot; 1992 May; 45(5):557-68. PubMed ID: 1512942
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [A study on the concentrations of levofloxacin in the gallbladder tissue and bile of patients].
    Hukagawa H; Noga K
    Jpn J Antibiot; 1992 Mar; 45(3):253-7. PubMed ID: 1512921
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Laboratory and clinical studies on levofloxacin].
    Tanaka K; Iwamoto M; Maesaki S; Koga H; Kohno S; Hara K; Sugawara K; Kaku M; Kusano S; Sakito O
    Jpn J Antibiot; 1992 May; 45(5):548-56. PubMed ID: 1512941
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Levofloxacin concentrations in serum, sputum and lung tissue: evaluation of its efficacy according to breakpoint].
    Fujita A; Miya T; Tanaka R; Hirayama S; Isaka H; Ono Y; Koshiishi Y; Goya T
    Jpn J Antibiot; 1999 Nov; 52(11):661-6. PubMed ID: 10659442
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Pharmacokinetic and clinical evaluation of levofloxacin in obstetrics and gynecology].
    Cho N; Araki H; Kimura T; Shimizu A; Ichikawa K; Fukunaga K; Kunii K
    Jpn J Antibiot; 1992 Mar; 45(3):270-84. PubMed ID: 1512924
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Sputum penetration of levofloxacin and its clinical efficacy in patients with chronic lower respiratory tract infections].
    Nakamori Y; Tsuboi E; Narui K; Nakatani T; Nakata K; Sugi H
    Jpn J Antibiot; 1992 May; 45(5):539-47. PubMed ID: 1512940
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of a new quinolone, levofloxacin in patients with surgical infections.
    Morimoto K; Kinoshita H; Nakatani S; Sakai K; Fujimoto M; Ohno K; Ueda T; Ohmori K; Yamazaki O; Doi S
    Jpn J Antibiot; 1992 Mar; 45(3):258-64. PubMed ID: 1512922
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [In vitro antituberculous activity of ofloxacin and levofloxacin against multidrug-resistant tuberculosis and clinical outcomes].
    Tada A; Kawata N; Shibayama T; Takahashi S; Hirano A; Kimura G; Takeuchi M; Okada C; Soda R; Takahashi K
    Kekkaku; 2006 Apr; 81(4):337-44. PubMed ID: 16715942
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Levofloxacin in the field of dermatology].
    Kanzaki H; Torigoe R; Yamada T; Abe Y; Shimoe K; Akiyama H; Arata J; Umemura S; Katayama H; Nishihara O
    Jpn J Antibiot; 1992 May; 45(5):576-84. PubMed ID: 1512944
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanistic study of inhibition of levofloxacin absorption by aluminum hydroxide.
    Tanaka M; Kurata T; Fujisawa C; Ohshima Y; Aoki H; Okazaki O; Hakusui H
    Antimicrob Agents Chemother; 1993 Oct; 37(10):2173-8. PubMed ID: 8257141
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Treatment of gonococcal urethritis].
    Osato K; Katsukawa C; Makino M
    Jpn J Antibiot; 1991 Nov; 44(11):1206-10. PubMed ID: 1784071
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of bile duct ligation and unilateral nephrectomy on brain concentration and convulsant potential of the quinolone antibacterial agent levofloxacin in rats.
    Akahane K; Ohkawara S; Nomura M; Kato M
    Fundam Appl Toxicol; 1996 Feb; 29(2):280-6. PubMed ID: 8742326
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Concentration of levofloxacin in cervical mucus and its clinical effects on cervicitis.
    Chimura T; Arai M; Onuma Y; Oda T; Kawagoe S; Kunii K; Saito T; Saito N; Sato F; Numazaki M; Matsuo M; Murayama K; Morizaki N
    Jpn J Antibiot; 1997 Nov; 50(11):871-7. PubMed ID: 9651605
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clinical pharmacology and efficacy of levofloxacin in elderly patients].
    Aoki N; Usuda Y; Koda Y; Takasawa T; Wakabayashi N; Hayashi S; Nitta I; Honma C; Watanabe K
    Jpn J Antibiot; 1992 May; 45(5):530-8. PubMed ID: 1512939
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Pharmacokinetic and clinical evaluation of levofloxacin in obstetrical and gynecological field].
    Matsuda S; Oh K; Hirayama H
    Jpn J Antibiot; 1992 Mar; 45(3):285-92. PubMed ID: 1512925
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of the corneal epithelium on the intraocular penetration of fluoroquinolone ophthalmic solution.
    Fukuda M; Inoue A; Sasaki K; Takahashi N
    Jpn J Ophthalmol; 2004; 48(2):93-6. PubMed ID: 15060787
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Antituberculosis effect of levofloxacin].
    Lu Y; Zhu L; Duan L
    Zhonghua Jie He He Hu Xi Za Zhi; 2000 Jan; 23(1):50-4. PubMed ID: 11778184
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Premarketing population pharmacokinetic study of levofloxacin in normal subjects and patients with infectious diseases.
    Tanigawara Y; Nomura H; Kagimoto N; Okumura K; Hori R
    Biol Pharm Bull; 1995 Feb; 18(2):315-20. PubMed ID: 7742805
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Permeability and concentration of levofloxacin in epithelial lining fluid in patients with lower respiratory tract infections.
    Zhang J; Xie X; Zhou X; Chen YQ; Yu JC; Cao GY; Wu XJ; Shi YG; Zhang YY
    J Clin Pharmacol; 2010 Aug; 50(8):922-8. PubMed ID: 20035039
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.